HP Ingredients Gets ParActin Patent

February 24, 2012

HP Ingredients may have the next winning ingredient for support of autoimmune disorders, as indicated by a U.S. patent the company just received for ParActin.

HP Ingredients (Bradenton, FL) may have the next winning ingredient for support of autoimmune disorders, as indicated by a U.S. patent the company just received for ParActin.

ParActin is a unique composition of Labdane diterpenes isolated from the Asian plant Andrographic paniculata. The company says ParActin may work against autoimmune disorders by activating PPARγ receptors in the body, which then inhibit proinflammatory signals.

If ParActin can really alleviate proflammatory signals, there may be potential for its use in asthma, Alzheimer’s, and a host of other serious conditions. And consumers may have a viable and natural alternative to auto-immune disease drugs and NSAIDs-both of which have been associated with their own potential side effects.

HP Ingredients says both in vitro and in vivo studies have demonstrated ParActin’s low and high-dose stimulation of the body’s immune response. The company adds that the ingredient has low toxicity and has not exhibited any harmful side effects.

Related Content:

News